Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

B. Hoogwerf · SciRah

Researcher profile · Semantic Scholar

B. Hoogwerf

Share profile

B. Hoogwerf — researcher profile on SciRah

h-index: 55
Works: 192
Citations: 20K

Most-cited papers

Nutrition Recommendations and Interventions for Diabetes
J. Bantle, J. Wylie-Rosett, A. Albright, C. Apovian +7 more
2008Diabetes Care1,711 citations Open access
Semantic Scholar
Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial.
rosiglitazone Medication Trial Investigators, Theodora S Temelkova-Kurktschiev, H. Gerstein, S. Yusuf +11 more
2006The Lancet1,710 citations Open access
Semantic Scholar
Effect of intensive treatment of hyperglycemia on microvascular complications of type 2 diabetes in ACCORD: a randomized trial
F. Ismail-Beigi, T. Craven, M. Banerji, J. Basile +19 more
2010The Lancet1,329 citations Open access
Semantic Scholar
The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study
D. Bonds, Michael E. Miller, R. Bergenstal, J. Buse +13 more
2010British medical journal945 citations Open access
Semantic Scholar
Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6): a randomised, open-label study.
J. Buse, M. Nauck, T. Forst, W. Sheu +8 more
2013The Lancet567 citations
Semantic Scholar
Use of Twice-Daily Exenatide in Basal Insulin–Treated Patients With Type 2 Diabetes
J. Buse, R. Bergenstal, L. Glass, C. R. Heilmann +4 more
2011Annals of Internal Medicine542 citations Open access
Semantic Scholar
Effects of Cardiac Autonomic Dysfunction on Mortality Risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial
R. Pop-Busui, G. Evans, H. Gerstein, V. Fonseca +6 more
2010Diabetes Care514 citations Open access
Semantic Scholar
The Effect of Adding Exenatide to a Thiazolidinedione in Suboptimally Controlled Type 2 Diabetes
B. Zinman, B. Hoogwerf, Santiago Durán García, D. Milton +4 more
2007Annals of Internal Medicine474 citations
Semantic Scholar
Nutrition principles and recommendations in diabetes.
M. Franz, J. Bantle, C. Beebe, J. Brunzell +8 more
2004Diabetes Care392 citations Open access
Semantic Scholar
Efficacy of GLP-1 receptor agonists and DPP-4 inhibitors: meta-analysis and systematic review.
V. Aroda, R. Henry, Jenny Han, Wen-Ying Huang +3 more
2012Clinical Therapeutics267 citations Open access
Semantic Scholar
Glucagon-Like Peptide 1 Receptor Agonist or Bolus Insulin With Optimized Basal Insulin in Type 2 Diabetes
M. Diamant, M. Nauck, R. Shaginian, J. Malone +6 more
2014Diabetes Care215 citations
Semantic Scholar
Evaluation of Diabetic Foot Ulcer Healing With Hyperspectral Imaging of Oxyhemoglobin and Deoxyhemoglobin
A. Nouvong, B. Hoogwerf, E. Mohler, B. Davis +2 more
2009Diabetes Care198 citations Open access
Semantic Scholar
Serum uric acid is an independent predictor of all-cause mortality in patients at high risk of cardiovascular disease: a preventive cardiology information system (PreCIS) database cohort study.
A. Ioachimescu, D. Brennan, B. Hoar, S. Hazen +1 more
2008Arthritis & Rheumatism197 citations
Semantic Scholar
Hypothyroidism and Moderate Subclinical Hypothyroidism Are Associated with Increased All-Cause Mortality Independent of Coronary Heart Disease Risk Factors: A PreCIS Database Study
C. McQuade, Mario Skugor, D. Brennan, B. Hoar +2 more
2011Thyroid186 citations
Semantic Scholar
Risk of Cardiovascular Disease Events in Patients With Type 2 Diabetes Prescribed the Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Exenatide Twice Daily or Other Glucose-Lowering Therapies
J. Best, B. Hoogwerf, W. Herman, E. Pelletier +3 more
2010Diabetes Care173 citations Open access
Semantic Scholar
Nutrition Recommendations and Interventions for Diabetes–2006
J. Bantle, J. Wylie-Rosett, A. Albright, C. Apovian +7 more
2006Diabetes Care157 citations Open access
Semantic Scholar
Obesity and glycemic control in patients with diabetes mellitus: Analysis of physician electronic health records in the US from 2009-2011.
J. Bae, M. Lage, D. Mo, D. Nelson +1 more
2016Journal of diabetes and its complications133 citations Open access
Semantic Scholar
Effects of vitamin E on cardiovascular outcomes in people with mild-to-moderate renal insufficiency: results of the HOPE study.
J. Mann, E. Lonn, Q. Yi, H. Gerstein +5 more
2004Kidney International119 citations Open access
Semantic Scholar
Renin-angiotensin system blockade and cardiovascular and renal protection.
B. Hoogwerf
2010American Journal of Cardiology107 citations
Semantic Scholar
Managing Type 2 Diabetes: Going Beyond Glycemic Control
M. Stolar, B. Hoogwerf, Stephen M Gorshow, P. Boyle +1 more
2008Journal of Managed Care Pharmacy104 citations Open access
Semantic Scholar
Teambuilding and leadership training in an internal medicine residency training program
J. Stoller, M. E. Rose, Rita Lee, Colleen M Dolgan +1 more
2004Journal of general internal medicine89 citations Open access
Semantic Scholar
Risk factors for renal replacement therapy in the Early Treatment Diabetic Retinopathy Study (ETDRS), Early Treatment Diabetic Retinopathy Study Report No. 26.
M. Cusick, E. Chew, B. Hoogwerf, E. Agrón +3 more
2004Kidney International88 citations Open access
Semantic Scholar
Association of triglyceride-to-HDL cholesterol ratio with heart rate recovery.
M. Shishehbor, B. Hoogwerf, M. Lauer
2004Diabetes Care86 citations Open access
Semantic Scholar
Pramlintide, the synthetic analogue of amylin: physiology, pathophysiology, and effects on glycemic control, body weight, and selected biomarkers of vascular risk
B. Hoogwerf, K. Doshi, Dima L. Diab
2008Vascular Health and Risk Management80 citations Open access
Semantic Scholar
Baseline Factors Associated With Glycemic Control and Weight Loss When Exenatide Twice Daily Is Added to Optimized Insulin Glargine in Patients With Type 2 Diabetes
J. Rosenstock, S. Shenouda, R. Bergenstal, J. Buse +5 more
2012Diabetes Care71 citations Open access
Semantic Scholar
Complications of Diabetes Mellitus
B. Hoogwerf
200556 citations
Semantic Scholar
Gender Differences in Utilization of Effective Cardiovascular Secondary Prevention: A Cleveland Clinic Prevention Database Study
L. Cho, B. Hoogwerf, Julie C. Huang, D. Brennan +1 more
2008Journal of Women's Health53 citations Open access
Semantic Scholar
Emerging cardiovascular risk factors that account for a significant portion of attributable mortality risk in chronic kidney disease.
M. Shishehbor, Leonardo P. J. Oliveira, M. Lauer, D. Sprecher +4 more
2007American Journal of Cardiology45 citations Open access
Semantic Scholar
Clinical course of nonalcoholic fatty liver disease: an assessment of severity, progression, and outcomes
J. Simeone, J. Bae, B. Hoogwerf, Qian Li +4 more
2017Clinical Epidemiology43 citations Open access
Semantic Scholar
Safety and Tolerability of Acarbose in the Treatment of Type 1 and Type 2 Diabetes Mellitus
D. Neuser, A. Benson, Andreas Brückner, R. Goldberg +2 more
2005Clinical drug investigation38 citations
Semantic Scholar
Perioperative management of diabetes mellitus: how should we act on the limited evidence?
B. Hoogwerf
2006Cleveland Clinic journal of medicine36 citations
Semantic Scholar
Association of SF-36 with coronary artery disease risk factors and mortality: a PreCIS study.
Jianping Zhang, L. Pozuelo, D. Brennan, B. Hoar +1 more
2009Preventive Cardiology35 citations Open access
Semantic Scholar
Effects of exenatide on kidney function, adverse events, and clinical end points of kidney disease in type 2 diabetes.
Katherine R. Tuttle, C. R. Heilmann, B. Hoogwerf, Carl Brown +1 more
2013American Journal of Kidney Diseases33 citations Open access
Semantic Scholar
Does intensive therapy of type 2 diabetes help or harm? Seeking accord on ACCORD.
B. Hoogwerf
2008Cleveland Clinic journal of medicine31 citations
Semantic Scholar
2006-2007 American Diabetes Association Nutrition Recommendations: issues for practice translation.
J. Wylie-Rosett, A. Albright, C. Apovian, N. Clark +8 more
2007Journal of the American Dietetic Association29 citations
Semantic Scholar
Cleveland Clinic Cardiovascular Intensive Care Unit Insulin Conversion Protocol
L. Olansky, Sharon Sam, C. Lober, J. Yared +1 more
2009Journal of Diabetes Science and Technology27 citations Open access
Semantic Scholar
Association of dyslipidemia and effects of statins on nonmacrovascular diseases.
S. Baghdasarian, H. Jneid, B. Hoogwerf
2004Clinical Therapeutics27 citations
Semantic Scholar
Health and economic outcomes for exenatide once weekly, insulin, and pioglitazone therapies in the treatment of type 2 diabetes: a simulation analysis
J. Gaebler, G. Soto-Campos, P. Alperin, M. Cohen +7 more
2012Vascular Health and Risk Management25 citations Open access
Semantic Scholar
Factors associated with stroke, myocardial infarction, ischemic heart disease, unstable angina, or mortality in patients from real world clinical practice with newly-diagnosed type 2 diabetes and early glycemic control
C. Alatorre, B. Hoogwerf, M. Deeg, D. Nelson +3 more
2018Current Medical Research and Opinion22 citations
Semantic Scholar
Ultra Rapid-Acting Inhaled Insulin Improves Glucose Control in Patients With Type 2 Diabetes Mellitus.
P. Levin, B. Hoogwerf, J. Snell-Bergeon, T. Vigers +2 more
2020Endocrine Practice21 citations Open access
Semantic Scholar
Relation of diurnal blood pressure variation and triglyceride-to-high-density lipoprotein cholesterol ratio in patients without diabetes mellitus.
M. B. Davidson, D. Vidt, B. Hoogwerf, D. Brotman
2005American Journal of Cardiology21 citations
Semantic Scholar
Statins may increase diabetes, but benefit still outweighs risk
B. Hoogwerf
2023Cleveland Clinic journal of medicine20 citations Open access
Semantic Scholar
RESULTS OF A 24-WEEK TRIAL OF TECHNOSPHERE INSULIN VERSUS INSULIN ASPART IN TYPE 2 DIABETES.
B. Hoogwerf, K. Pantalone, Marina Basina, Marisa C Jones +2 more
2021Endocrine Practice20 citations Open access
Semantic Scholar
Addition of exenatide twice daily to basal insulin for the treatment of type 2 diabetes: clinical studies and practical approaches to therapy
Garry S. Tobin, M. Cavaghan, B. Hoogwerf, J. McGill
2012International journal of clinical practice19 citations Open access
Semantic Scholar
Effects of Exenatide on Diabetes, Obesity, Cardiovascular Risk Factors, and Hepatic Biomarkers in Patients with Type 2 Diabetes
Loretta L. Nielsen, T. Okerson, J. Holcombe, B. Hoogwerf
2008Journal of Diabetes Science and Technology19 citations Open access
Semantic Scholar
Risk Factors for Nocturnal Hypoglycemia in Insulin-treated Patients With Type 2 Diabetes: A Secondary Analysis of Observational Data Derived From an Integrated Clinical Trial Database.
J. Bae, Ran Duan, H. Fu, B. Hoogwerf
2017Clinical Therapeutics18 citations Open access
Semantic Scholar
Exenatide and pramlintide: new glucose-lowering agents for treating diabetes mellitus.
B. Hoogwerf
2006Cleveland Clinic journal of medicine18 citations
Semantic Scholar
Understanding inhaled Technosphere Insulin: Results of an early randomized trial in type 1 diabetes mellitus
J. McGill, Daniel Weiss, M. Grant, Marisa C Jones +2 more
2020Journal of Diabetes17 citations
Semantic Scholar
Diabetes mellitus--overview.
B. Hoogwerf, J. Sferra, B. Donley
2006Foot and Ankle Clinics17 citations
Semantic Scholar
Risk factors for 30-day readmission following hypoglycemia-related emergency room and inpatient admissions
Matthew F. Emons, Jay P. Bae, B. Hoogwerf, S. Kindermann +2 more
2016BMJ Open Diabetes Research & Care16 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. Franz×4
Invite
M. Franz — researcher profile on SciRah
E. Mayer-Davis×4
Invite
E. Mayer-Davis — researcher profile on SciRah
A. Mooradian×4
Invite
A. Mooradian — researcher profile on SciRah
M. Wheeler×4
Invite
M. Wheeler — researcher profile on SciRah

×4

Invite

J. Buse — researcher profile on SciRah

C. R. Heilmann×4

Invite

C. R. Heilmann — researcher profile on SciRah

Invite

D. Brennan — researcher profile on SciRah

Invite

J. Bantle — researcher profile on SciRah

J. Wylie-Rosett×3

Invite

J. Wylie-Rosett — researcher profile on SciRah

Invite

C. Apovian — researcher profile on SciRah

Invite

N. Clark — researcher profile on SciRah

A. Lichtenstein×3

Invite

A. Lichtenstein — researcher profile on SciRah